162,163,164 Exa-cel (Casgevy) was approved in November 2023 as the first gene-editing therapeutic drug based on the CRISPR/Cas9 system for treating sickle cell disease (SCD) and transfusion-dependent -thalassemia (TDT)
If using both, apply vitamin C in the morning and GHK-Cu serum in the evening, or space them 15+ minutes apart
Nausea has kicked in, you're vomiting in the middle of the work day, your moles are getting suspiciously darker, and theres some new hyperpigmentation that popped up on the right side of your face
Retatrutide titration: Why it matters Titration is a process of gradually increasing the dose of a medication
Employers and insurers must consider the potential costs of covering the drugs for enrollees perhaps for them to use indefinitely against the potential savings associated with losing weight, such as a lower chance of diabetes or joint problems